Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.49 USD
Change Today +0.04 / 1.63%
Volume 23.1K
ROSG On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 1:53 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gerald Dogon

External Director, Chairman of Audit Committee and Member of Compensation Committee,Rosetta Genomics, Ltd.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 4 different industries.

See Board Relationships
75--

Background*

Mr. Gerald Dogon served as the Chief Financial Officer of DSP Communications Inc., from August 1994 to October 1998. Mr. Dogon served as an Executive Vice President of DSP Communications Inc. from July 1996 to October 1998 and Senior Vice President from August 1994 to July 1996. From December 1987 to August 1994, Mr. Dogon served various senior financial positions with several Israeli companies, including Nilit Ltd., Mul-T-Lock Ltd., Israel General Bank Ltd. and Indigo ...

Read Full Background

Corporate Headquarters*

10 Plaut Street
Rehovot, -- 76706

Israel

Phone: 972 73 222 0700
Fax: 972 73 222 0701

Board Members Memberships*

2005-Present
Director
2007-Present
External Director, Chairman of Audit Committee and Member of Compensation Committee

Education*

Bachelor's Degree
University of Cape Town
BA
University of Cape Town
Bachelor's Degree
Columbia University
MBA
Columbia University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROSG:US $2.49 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Mark Christopher Capone Chief Executive Officer and President
Myriad Genetics Inc.
$568.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$660.0K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$416.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ROSETTA GENOMICS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.